-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on HCA Healthcare, Lowers Price Target to $485

Benzinga·07/28/2026 16:47:46
语音播报
Goldman Sachs analyst Scott Fidel maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $558 to $485.